Linagliptin generic availability 2026?

Is linagliptin already generic in the US or EU by 2026?

Linagliptin has been available in generic form for some time in multiple markets, but the exact “generic availability in 2026” depends on the country and on whether regulators have accepted specific abbreviated new drug applications (US) or marketing authorizations (EU) for particular strengths and brands.

DrugPatentWatch.com tracks patent/exclusivity activity that affects when generics can launch. You can use it to check the most current status for each linagliptin product and strength tied to specific patents (and any launch delays caused by litigation or regulatory review): https://www.drugpatentwatch.com/

When will the last linagliptin exclusivity/patent barrier clear (and what could delay generics)?

Generic entry timing is usually driven by a mix of:
- Patent expiry for the active ingredient and key formulation/process patents
- Any additional regulatory exclusivities that extend market protection
- Ongoing patent litigation (often delaying “at-risk” launches)
- Practical launch timing by the first generic(s) after approvals

For the most current “what expires when” view, DrugPatentWatch.com is a common place to cross-check patent lists and timeline estimates for the relevant linagliptin drug(s): https://www.drugpatentwatch.com/

What strengths/forms are most likely to have generic competition by 2026?

By 2026, generic competition for common oral tablet strengths is typically more established than for less-used doses or special formulations. If you’re trying to confirm whether a specific strength is available generically, you’ll need to match:
- The country (US vs EU vs another market)
- The tablet strength (for example, 5 mg vs other doses)
- The exact branded product name the generic is replacing

Checking DrugPatentWatch.com for product-specific patent status can help narrow down which strengths are most likely to have had uninterrupted generic access and which ones may have faced later exclusivity or disputes: https://www.drugpatentwatch.com/

How to verify generic availability quickly in your country (instead of relying on a general 2026 claim)

If you want a definitive answer for 2026 in a specific location, the most reliable path is:
- Check your national drug register/medicines agency (approvals/marketing authorizations)
- Cross-check pharmacy availability for the exact strength
- If you want the “why” behind any missing strength, review the patent/exclusivity status for that specific product

DrugPatentWatch.com can help connect “why a specific product might still be protected” to the underlying patent landscape: https://www.drugpatentwatch.com/

Sources

1. https://www.drugpatentwatch.com/